A detailed history of Glenmede Trust CO Na transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 37,938 shares of ELAN stock, worth $532,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,938
Previous 38,178 0.63%
Holding current value
$532,649
Previous $550,000 1.09%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.85 - $15.47 $2,844 - $3,712
-240 Reduced 0.63%
37,938 $556,000
Q2 2024

Aug 14, 2024

SELL
$12.93 - $18.45 $87,109 - $124,297
-6,737 Reduced 15.0%
38,178 $550,000
Q1 2024

May 15, 2024

SELL
$14.37 - $16.46 $60,167 - $68,918
-4,187 Reduced 8.53%
44,915 $731,000
Q4 2023

Feb 13, 2024

SELL
$8.6 - $14.94 $629,485 - $1.09 Million
-73,196 Reduced 59.85%
49,102 $731,000
Q3 2023

Nov 14, 2023

SELL
$9.81 - $12.62 $1.65 Million - $2.12 Million
-167,764 Reduced 57.84%
122,298 $1.37 Million
Q1 2023

May 15, 2023

BUY
$8.79 - $14.58 $1.43 Million - $2.37 Million
162,224 Added 126.9%
290,062 $2.73 Million
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $2.2 Million - $2.61 Million
-191,397 Reduced 59.95%
127,838 $1.56 Million
Q3 2022

Nov 16, 2022

SELL
$12.41 - $32.42 $4.9 Million - $12.8 Million
-394,508 Reduced 55.27%
319,235 $3.96 Million
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $1.62 Million - $2.2 Million
-82,765 Reduced 10.39%
713,743 $14 Million
Q1 2022

May 16, 2022

SELL
$24.65 - $29.0 $207,133 - $243,687
-8,403 Reduced 1.04%
796,508 $20.8 Million
Q4 2021

Feb 15, 2022

SELL
$27.74 - $34.09 $775,083 - $952,508
-27,941 Reduced 3.35%
804,911 $22.8 Million
Q3 2021

Nov 15, 2021

SELL
$29.2 - $36.72 $79,248 - $99,658
-2,714 Reduced 0.32%
832,852 $26.6 Million
Q2 2021

Aug 16, 2021

BUY
$28.76 - $35.98 $92,981 - $116,323
3,233 Added 0.39%
835,566 $29 Million
Q1 2021

May 18, 2021

BUY
$27.85 - $34.49 $740,615 - $917,192
26,593 Added 3.3%
832,333 $24.5 Million
Q4 2020

Feb 16, 2021

BUY
$27.53 - $33.79 $103,402 - $126,915
3,756 Added 0.47%
805,740 $24.7 Million
Q3 2020

Nov 16, 2020

BUY
$21.1 - $29.13 $2.68 Million - $3.7 Million
127,038 Added 18.82%
801,984 $22.4 Million
Q2 2020

Aug 14, 2020

SELL
$18.94 - $24.93 $2.51 Million - $3.31 Million
-132,777 Reduced 16.44%
674,946 $14.5 Million
Q4 2019

Feb 12, 2020

SELL
$25.29 - $29.45 $6.77 Million - $7.88 Million
-267,703 Reduced 24.89%
807,723 $23.8 Million
Q3 2019

Nov 14, 2019

SELL
$25.62 - $34.96 $455,523 - $621,588
-17,780 Reduced 1.63%
1,075,426 $28.6 Million
Q2 2019

Aug 13, 2019

BUY
$31.11 - $34.79 $15.9 Million - $17.8 Million
510,967 Added 87.76%
1,093,206 $36.9 Million
Q1 2019

May 14, 2019

BUY
$29.0 - $32.83 $16.9 Million - $19.1 Million
582,239 New
582,239 $18.7 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.66B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.